Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

Search this Article

Author(s)

    • JIKO Mari
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • YANO Ikuko
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • SATO Eriko
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • TAKAHASHI Kazushige
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • MOTOHASHI Hideyuki
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • MASUDA Satohiro
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • OKUDA Masahiro
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University
    • ITO Noriyuki
    • Department of Urology, Graduate School of Medicine, Kyoto University
    • NAKAMURA Eijiro
    • Department of Urology, Graduate School of Medicine, Kyoto University
    • SEGAWA Takehiko
    • Department of Urology, Graduate School of Medicine, Kyoto University
    • OGAWA Osamu
    • Department of Urology, Graduate School of Medicine, Kyoto University
    • INUI Ken-ichi
    • Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University

Journal

  • International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology

    International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology 12(4), 284-290, 2007-08-01

References:  37

Codes

  • NII Article ID (NAID)
    10020000038
  • NII NACSIS-CAT ID (NCID)
    AA11086579
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    13419625
  • Data Source
    CJP 
Page Top